Preliminary evidence of blunted humoral response to SARS-Cov-2 (MRNA) vaccine in multiple sclerosis patients treated with ocrelizumab

https://doi.org/10.1016/j.jns.2021.117795Get rights and content

Cited by (0)

View Abstract